The Effect of Sertraline on the Quality of Life for Children and Adolescents with Anxiety Disorder

Overview

Journal Noro Psikiyatr Ars

Date 2017 Apr 1

PMID 28360592

Citations 2

Authors

Nursu Cakin Memik

Isik Karakaya

Ozlem Yildiz

Sahika Sismanlar

Cigdem Caglayan

Belma Agaoglu

Affiliations

Soon will be listed here.

Abstract

Introduction: In this study, we aimed to determine the changes in quality of life of children/adolescents with anxiety disorders during six months of sertraline treatment, to investigate parent-child/adolescent concordance in perception of quality of life and to examine the effect of treatment on children/adolescents.

Methods: In this study, 30 patients with anxiety disorders according to criteria specified in Diagnostic and Statistical Manual of Mental Disorders, 4. Edition (DSM-IV) were assigned to sertraline treatment. The patients were evaluated using the Pediatric Quality of Life Inventory (PedsQL), State-Trait Anxiety Inventory for Children, Clinical Global Impression Scale (CGI) and the Children's Global Assessment Scale (CGAS) at 0th, 2 and 6 months.

Results: PedsQL total scores increased significantly with the treatment in children and adolescents (p<.001), however, no differences were observed in parent proxy report (p=.326). The mean CGAS score was 59.85±7.73 at the beginning of treatment and 73.70±7.01 at the end of treatment (p<.001). The average CGI score decreased from 4.68±.96 to 2.27±.84.

Conclusion: It was observed that perception of quality of life in children and adolescents with anxiety disorders increased with the treatment.

Citing Articles

Family functioning and quality of life among children with anxiety disorder and healthy controls. A cross-sectional study.

Ozturk Y, Ozyurt G, Akay A Sao Paulo Med J. 2018; 136(4):346-353.

PMID: 30110079 PMC: 9881690. DOI: 10.1590/1516-3180.2018.0145240418.

The anxiolytic-like effects of puerarin are associated with the changes of monoaminergic neurotransmitters and biosynthesis of allopregnanolone in the brain.

Qiu Z, Zhong D, He J, Liu X, Chen J, Nie H Metab Brain Dis. 2017; 33(1):167-175.

PMID: 29101599 DOI: 10.1007/s11011-017-0127-9.

References

Carrera M, Herran A, Ayuso-Mateos J, Sierra-Biddle D, Ramirez M, Ayestaran A . Quality of life in early phases of panic disorder: predictive factors. J Affect Disord. 2006; 94(1-3):127-34. DOI: 10.1016/j.jad.2006.03.006. View

Verhulst F, van der Ende J, Ferdinand R, Kasius M . The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents. Arch Gen Psychiatry. 1997; 54(4):329-36. DOI: 10.1001/archpsyc.1997.01830160049008. View

Sanderson W, DiNardo P, Rapee R, Barlow D . Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. J Abnorm Psychol. 1990; 99(3):308-12. DOI: 10.1037//0021-843x.99.3.308. View

Bernstein G, Borchardt C, Perwien A . Anxiety disorders in children and adolescents: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1996; 35(9):1110-9. DOI: 10.1097/00004583-199609000-00008. View

Candilis P, McLean R, Otto M, Manfro G, Worthington 3rd J, Penava S . Quality of life in patients with panic disorder. J Nerv Ment Dis. 1999; 187(7):429-34. DOI: 10.1097/00005053-199907000-00006. View

Dahl A, Ravindran A, Allgulander C, Kutcher S, Austin C, Burt T . Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors. Acta Psychiatr Scand. 2005; 111(6):429-35. DOI: 10.1111/j.1600-0447.2005.00529.x. View

Orvaschel H, Chambers W, Tabrizi M, Johnson R . Retrospective assessment of prepubertal major depression with the Kiddie-SADS-e. J Am Acad Child Psychiatry. 1982; 21(4):392-7. DOI: 10.1016/s0002-7138(09)60944-4. View

Williams T, Miller B . Pharmacologic management of anxiety disorders in children and adolescents. Curr Opin Pediatr. 2003; 15(5):483-90. DOI: 10.1097/00008480-200310000-00007. View

Fergusson D, Horwood L, Lynskey M . Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds. J Am Acad Child Adolesc Psychiatry. 1993; 32(6):1127-34. DOI: 10.1097/00004583-199311000-00004. View

10.

Bastiaansen D, Koot H, Ferdinand R, Verhulst F . Quality of life in children with psychiatric disorders: self-, parent, and clinician report. J Am Acad Child Adolesc Psychiatry. 2004; 43(2):221-30. DOI: 10.1097/00004583-200402000-00019. View

11.

Reinblatt S, Riddle M . Selective serotonin reuptake inhibitor-induced apathy: a pediatric case series. J Child Adolesc Psychopharmacol. 2006; 16(1-2):227-33. DOI: 10.1089/cap.2006.16.227. View

12.

Rynn M, Siqueland L, Rickels K . Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry. 2001; 158(12):2008-14. DOI: 10.1176/appi.ajp.158.12.2008. View

13.

Stein M, Kean Y . Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry. 2000; 157(10):1606-13. DOI: 10.1176/appi.ajp.157.10.1606. View

14.

Stein M, Fyer A, Davidson J, Pollack M, Wiita B . Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. Am J Psychiatry. 1999; 156(5):756-60. DOI: 10.1176/ajp.156.5.756. View

15.

Stengler-Wenzke K, Kroll M, Matschinger H, Angermeyer M . [Subjective quality of life of patients with obsessive-compulsive disorder compared to the general population]. Psychiatr Prax. 2006; 33(7):350-2. DOI: 10.1055/s-2006-940145. View

16.

Labellarte M, Walkup J, Riddle M . The new antidepressants. Selective serotonin reuptake inhibitors. Pediatr Clin North Am. 1999; 45(5):1137-55, ix. DOI: 10.1016/s0031-3955(05)70066-3. View

17.

Varni J, Burwinkle T, Seid M, Skarr D . The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003; 3(6):329-41. DOI: 10.1367/1539-4409(2003)003<0329:tpaapp>2.0.co;2. View

18.

Spitzer R, Kroenke K, Linzer M, Hahn S, Williams J, deGruy 3rd F . Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA. 1995; 274(19):1511-7. View

19.

Meltzer-Brody S, Davidson J . Completeness of response and quality of life in mood and anxiety disorders. Depress Anxiety. 2000; 12 Suppl 1:95-101. DOI: 10.1002/1520-6394(2000)12:1+<95::AID-DA14>3.0.CO;2-U. View

20.

Strauss C . Behavioral assessment and treatment of overanxious disorder in children and adolescents. Behav Modif. 1988; 12(2):234-51. DOI: 10.1177/01454455880122004. View